PLRX - Pliant Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.49 0.07 (4.7%)	---	-0.01 (-0.64%)	-0.01 (-0.64%)	0.02 (1.34%)	0.07 (4.64%)	-0.07 (-4.29%)	-0.07 (-4.29%)

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.71
Diluted EPS:: -0.71
Basic P/E:: -2.1972
Diluted P/E:: -2.1972
RSI(14) 1m:: 0.0
VWAP:: 1.57
RVol:: 0.7771

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.6 -0.02 (-1.18%)	Oct 15 16:29
1m	Price increase 1m	1.62 +0.02 (+1.25%)	Oct 15 16:28
1m	Price decrease 1m	1.56 -0.02 (-1.27%)	Oct 15 14:36
60m	Price increase 60m	1.57 +0.07 (+5.03%)	Oct 15 09:58
1m	Price increase 1m	1.56 +0.02 (+1.3%)	Oct 15 09:53